Ingredient intelligence

Alpha-lipoic acid

Antioxidant · Thioctic Acid · C8H14O2S2

CompareExplore biology

Alpha-lipoic acid is a dithiol of mitochondrial dehydrogenase complexes and an amphipathic redox agent.

Repeated (2 studies)Two independent human studies point the same way; more replication would strengthen this.

Any underlined term can be tapped for an everyday-English translation.

Molecular identity

Two-dimensional chemical structure of Alpha-lipoic acid
Formula
C8H14O2S2
Molecular weight
206.33 g/mol
PubChem CID
864
ChEBI
CHEBI:16494
Open PubChem record →

Biological targets

  • Dihydrolipoamide dehydrogenase (DLD)

    high confidence

    targets · enzyme

    UniProt P09622
  • NF-E2-related factor 2 (NFE2L2)

    low confidence

    activates · receptor

    UniProt Q16236

Molecules & genes

Molecules

  • Alpha-lipoic acidC8H14O2S2 · 206.33 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
Alpha-lipoic acidAlpha-lipoic acidDihydrolipoamide dehydrog…DLDPyruvate metabolism and c…Detoxification of reactiv…Cellular energy metabolismOxidative stress response

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome

3 lower-confidence relationships are hidden at this filter level. Use “Show more biology” to include them.

Text alternative for this network
  • Alpha-lipoic acid is molecule Alpha-lipoic acid — high confidence
  • Alpha-lipoic acid targets Dihydrolipoamide dehydrogenase (DLD) — high confidence
  • Dihydrolipoamide dehydrogenase (DLD) encoded by DLD — high confidence
  • DLD participates in Pyruvate metabolism and citric acid cycle — high confidence
  • DLD participates in Detoxification of reactive oxygen species — medium confidence
  • Pyruvate metabolism and citric acid cycle associated with Cellular energy metabolism — high confidence
  • Detoxification of reactive oxygen species associated with Cellular energy metabolism — medium confidence
  • Pyruvate metabolism and citric acid cycle associated with Oxidative stress response — medium confidence
  • Detoxification of reactive oxygen species associated with Oxidative stress response — medium confidence

Biological pathways

Pyruvate metabolism and citric acid cycle

high confidence

Lipoamide function in dehydrogenase complexes.

Reactome R-HSA-71406

Detoxification of reactive oxygen species

medium confidence

Redox cycling in both aqueous and phases.

Reactome R-HSA-3299685

Evidence engine

Moderate

Some human evidence exists, but replication or sample sizes are limited.

Skinceptor Evidence Index

61

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • Randomised controlled trial2
Total studies
2
Human studies
2
Largest sample
33
Range
2003–2003

Index breakdown

  • Study design quality90% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share67% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume50% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size51% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication67% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency0% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability0% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 2003

    Alpha-lipoic acid cream and photoaged facial skin: a randomised controlled trial

    Randomised controlled trialn = 33 · British Journal of Dermatology

  2. 2003

    Alpha-lipoic acid cream and photoageing endpoints: a randomised controlled trial

    Randomised controlled trialn = 33 · British Journal of Dermatology

Ingredient fingerprint

11 nodes · 15 relationships · seed "alpha-lipoic-acid"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

2 curated studies

Randomised controlled trialBritish Journal of Dermatology · 2003n = 33

Alpha-lipoic acid cream and photoaged facial skin: a randomised controlled trial

Reported modest improvement in photoaging scores versus vehicle on half-face assessment.

Limitations — Small sample; identifier not verified; subjective grading.

Randomised controlled trialBritish Journal of Dermatology · 2003n = 33

Alpha-lipoic acid cream and photoageing endpoints: a randomised controlled trial

Reported modest improvement in photoageing severity scores versus vehicle over 12 weeks.

Limitations — Single trial, partly subjective endpoints; identifier not verified during curation.

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources